Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size
Jiaxing Di, Zhili Du, Kangzeng Wu, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 1, pp. 105-114
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 73
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 1
Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction
Axelle Bois, Catarina Grandela, James Gallant, et al.
npj Regenerative Medicine (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
Ruvanthi N. Kularatne, Rachael M. Crist, Stęphan T. Stern
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 897-897
Open Access | Times Cited: 48
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
Pieter Vervaeke, Sven Even Borgos, Niek N. Sanders, et al.
Advanced Drug Delivery Reviews (2022) Vol. 184, pp. 114236-114236
Open Access | Times Cited: 39
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Mingdi Hu, Xiaoyan Li, Zhen You, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 36
Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
Xiao Xu, Tian Xia
ACS Nanoscience Au (2023) Vol. 3, Iss. 3, pp. 192-203
Open Access | Times Cited: 30
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury
Lauren E. Waggoner, Katelyn Miyasaki, Ester J. Kwon
Biomaterials Science (2023) Vol. 11, Iss. 12, pp. 4238-4253
Open Access | Times Cited: 27
On the mechanism of tissue-selective gene delivery by lipid nanoparticles
Seigo Kimura, Hideyoshi Harashima
Journal of Controlled Release (2023) Vol. 362, pp. 797-811
Open Access | Times Cited: 24
Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection
Jan Tůma, Y Chen, Michael G. Collins, et al.
Biochemistry (2023) Vol. 62, Iss. 24, pp. 3533-3547
Open Access | Times Cited: 21
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1266-1283
Open Access | Times Cited: 12
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70
Byron Brook, Valérie Duval, Soumik Barman, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 757
Closed Access | Times Cited: 9
Targeting Strategies for Site-Specific mRNA Delivery
Jiaxing Di, Pei Huang, Xiaoyuan Chen
Bioconjugate Chemistry (2024) Vol. 35, Iss. 4, pp. 453-456
Closed Access | Times Cited: 8
Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics
Kenji Miyazawa, Yun Liu, Hojjat Bazzazi
Frontiers in Nanotechnology (2024) Vol. 6
Open Access | Times Cited: 7
The dynamic process of mRNA delivery by lipid nanoparticles in vivo
Runpu Ma, Yuting Li, Yi Wei, et al.
Nano Today (2024) Vol. 57, pp. 102325-102325
Closed Access | Times Cited: 7
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice
Maho Kawaguchi, Marin Noda, Akari Ono, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 5, pp. 1401-1410
Open Access | Times Cited: 30
In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy
Oscar Escalona-Rayo, Ye Zeng, Renzo A. Knol, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115065-115065
Open Access | Times Cited: 20
Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity
Hojeong Shin, Seounghun Kang, Cheolhee Won, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 17554-17567
Closed Access | Times Cited: 20
Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution
Rasmus Münter, Esben Christensen, Thomas L. Andresen, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 29, pp. 450-459
Open Access | Times Cited: 18
A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs
Jiawu Wan, Jianmei Yang, Zongmei Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 16
Vasculature organotropism in drug delivery
A Amruta, Dalila Iannotta, Seth W. Cheetham, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115054-115054
Open Access | Times Cited: 15
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Pei Huang, Hongzhang Deng, Changrong Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top